查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738325

法醫基因組學市場－全球產業規模、佔有率、趨勢、機會和預測（按組件、技術、應用、地區和競爭細分，2020-2030 年）

Forensic Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Technique, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球法醫基因組學市場價值為 5.8715 億美元，預計到 2030 年將達到 13.4726 億美元，預測期內的複合年成長率為 14.85%。由於政府和私營部門增加對具有成本效益的法醫檢測技術的資金投入，市場正在經歷顯著擴張。這包括全球國營法醫實驗室分析物證的能力增強。日益成長的安全問題，尤其是在國際和國內機場，再加上犯罪活動的日益猖獗，進一步刺激了對先進法醫解決方案的需求。在法醫科學進步的推動下，法醫部門採用尖端設備也提高了調查效率。此外，執法機構越來越依賴基因組技術來破案，也推動了市場成長。值得注意的是，華盛頓大學和美國國土安全部於 2022 年利用 DNA 追蹤象牙走私網路的合作研究，體現了法醫基因組學在全球安全行動中日益擴大的作用。

市場概覽
預測期 2026-2030
2024年市場規模 5.8715億美元
2030年市場規模 13.4726億美元
2025-2030 年複合年成長率 14.85%
成長最快的領域 軟體
最大的市場 北美洲

關鍵市場促進因素

犯罪率上升，對先進法醫解決方案的需求增加

主要市場挑戰

道德問題和資料隱私問題

主要市場趨勢

法醫基因組學中人工智慧和機器學習的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球法醫基因體學市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按組件（試劑盒、分析儀和定序儀、軟體、耗材）
    • 依技術（毛細管電泳 {CE}、次世代定序 {NGS}、PCR 擴增）
    • 按應用（犯罪測試、親子鑑定和家庭測試、生物防禦、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按組件
    • 依技術
    • 按應用
    • 按地區

第6章：北美法醫基因體學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲法醫基因體學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太法醫基因體學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲法醫基因組學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲法醫基因組學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 13 章：全球法醫基因組學市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 15 章：競爭格局

  • Illumina, Inc.
  • Verogen, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN NV
  • GE Healthcare
  • Gene by Gene, Ltd.
  • Neogen Corporation
  • Eurofins Scientific SE
  • Othram Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14429

The Global Forensic Genomics Market was valued at USD 587.15 million in 2024 and is projected to reach USD 1347.26 million by 2030, growing at a CAGR of 14.85% during the forecast period. The market is experiencing notable expansion, driven by increased funding from both governmental and private sectors for cost-efficient forensic testing technologies. This includes enhanced capabilities for analyzing physical evidence in state-run forensic labs globally. Rising security concerns, especially at international and domestic airports, coupled with the growing prevalence of criminal activities, are further fueling demand for advanced forensic solutions. The adoption of cutting-edge equipment in forensic departments, bolstered by advancements in forensic science, is also enhancing investigative efficiency. Additionally, law enforcement agencies' growing reliance on genomic technologies to solve crimes is propelling market growth. Notably, collaborative research, such as the 2022 initiative by the University of Washington and U.S. Department of Homeland Security using DNA to trace ivory smuggling networks, exemplifies the expanding role of forensic genomics in global security operations.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 587.15 Million
Market Size 2030USD 1347.26 Million
CAGR 2025-203014.85%
Fastest Growing SegmentSoftware
Largest MarketNorth America

Key Market Drivers

Increasing Crime Rates and Demand for Advanced Forensic Solutions

The rise in violent crime globally is a key factor propelling the forensic genomics market, as law enforcement agencies turn to precise, advanced tools to improve investigative outcomes. Forensic genomics offers highly accurate DNA-based identification techniques crucial for solving complex cases. For instance, the FBI reported more than 1.3 million violent crimes in the U.S. in 2022. DNA technology has already been instrumental in resolving over 50,000 cases from 2010 to 2020, according to the U.S. Department of Justice. These figures underline the growing reliance on genomic analysis for cold cases and active investigations, reinforcing the demand for innovative and reliable forensic tools.

Key Market Challenges

Ethical Concerns and Data Privacy Issues

Despite its benefits, forensic genomics raises substantial ethical and data privacy concerns that hinder broader adoption. The practice of collecting and storing DNA-sometimes without clear consent-raises issues around individual rights and potential misuse. For example, collecting genetic material from suspects or their relatives can lead to questions about voluntary participation. Long-term storage of genetic profiles in national databases has sparked fears of surveillance and genetic discrimination. Regulatory bodies like the EU's GDPR impose strict controls on genetic data handling, while advocacy groups such as the ACLU and EFF have voiced concerns about the absence of comprehensive legal safeguards, especially in countries like the United States. These ethical dilemmas could limit public acceptance and regulatory flexibility.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Forensic Genomics

Artificial intelligence and machine learning are increasingly being integrated into forensic genomics to manage and analyze complex genomic data. AI-driven tools help streamline the interpretation of genetic information by identifying patterns and resolving DNA mixtures from multiple contributors-an essential capability in forensic investigations. Machine learning also enhances phenotypic prediction, enabling law enforcement to deduce physical traits from DNA when suspect databases offer no direct matches. These innovations increase accuracy, reduce turnaround times, and support real-time decision-making in active cases, signaling a technological shift toward automated and scalable forensic solutions.

Key Market Players

  • Illumina, Inc.
  • Verogen, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN N.V.
  • GE Healthcare
  • Gene by Gene, Ltd.
  • Neogen Corporation
  • Eurofins Scientific SE
  • Othram Inc.

Report Scope:

In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Forensic Genomics Market, By Component:

  • Kits
  • Analyzers & Sequencers
  • Software
  • Consumables

Forensic Genomics Market, By Technique:

  • Capillary Electrophoresis (CE)
  • Next-generation Sequencing (NGS)
  • PCR Amplification

Forensic Genomics Market, By Application:

  • Criminal Testing
  • Paternity & Familial Testing
  • Biodefense
  • Others

Forensic Genomics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Forensic Genomics Market.

Available Customizations:

Global Forensic Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Forensic Genomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Kits, Analyzers & Sequencers, Software, Consumables)
    • 5.2.2. By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification)
    • 5.2.3. By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Application
    • 5.3.4. By Region

6. North America Forensic Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Forensic Genomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Forensic Genomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Forensic Genomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application

7. Europe Forensic Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Forensic Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Forensic Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Forensic Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Forensic Genomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Forensic Genomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application

8. Asia-Pacific Forensic Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Forensic Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
    • 8.3.2. India Forensic Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Forensic Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Forensic Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Forensic Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application

9. South America Forensic Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Forensic Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Forensic Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Forensic Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application

10. Middle East and Africa Forensic Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Forensic Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Forensic Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Forensic Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Forensic Genomics Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Verogen, Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. Thermo Fischer Scientific, Inc.
  • 15.5. QIAGEN N.V.
  • 15.6. GE Healthcare
  • 15.7. Gene by Gene, Ltd.
  • 15.8. Neogen Corporation
  • 15.9. Eurofins Scientific SE
  • 15.10. Othram Inc.

16. Strategic Recommendations

17. About Us & Disclaimer